News
NNNN
12.70
+2.88%
0.36
Weekly Report: what happened at NNNN last week (0622-0626)?
Weekly Report · 5d ago
Weekly Report: what happened at NNNN last week (0615-0619)?
Weekly Report · 06/22 09:53
Top 3 Health Care Stocks You'll Regret Missing In Q2
Benzinga · 06/18 10:02
Weekly Report: what happened at NNNN last week (0608-0612)?
Weekly Report · 06/15 09:54
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 06/08 17:06
Anbio Biotechnology falls -22.7%
TipRanks · 06/08 16:06
Weekly Report: what happened at NNNN last week (0601-0605)?
Weekly Report · 06/08 09:52
Weekly Report: what happened at NNNN last week (0525-0529)?
Weekly Report · 06/01 09:54
Weekly Report: what happened at NNNN last week (0518-0522)?
Weekly Report · 05/25 09:56
Anbio Biotechnology Shareholders Approve Sweeping Capital and Governance Changes
TipRanks · 05/19 10:33
Weekly Report: what happened at NNNN last week (0511-0515)?
Weekly Report · 05/18 09:56
Weekly Report: what happened at NNNN last week (0504-0508)?
Weekly Report · 05/11 09:54
Weekly Report: what happened at NNNN last week (0427-0501)?
Weekly Report · 05/04 09:53
Anbio Biotechnology Calls May 15 Shareholder Votes on Sweeping Capital and Governance Overhaul
TipRanks · 04/27 23:02
Weekly Report: what happened at NNNN last week (0420-0424)?
Weekly Report · 04/27 09:54
Weekly Report: what happened at NNNN last week (0413-0417)?
Weekly Report · 04/20 09:52
Weekly Report: what happened at NNNN last week (0406-0410)?
Weekly Report · 04/13 09:55
Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio
Benzinga · 04/09 16:46
Weekly Report: what happened at NNNN last week (0330-0403)?
Weekly Report · 04/06 09:54
Weekly Report: what happened at NNNN last week (0323-0327)?
Weekly Report · 03/30 09:55
More
Webull provides a variety of real-time NNNN stock news. You can receive the latest news about ANBIO BIOTECHNOLOGY through multiple platforms. This information may help you make smarter investment decisions.
About NNNN
Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).